Checkpoint Therapeutics (NASDAQ:CKPT) Earns “Buy” Rating from D. Boral Capital
Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report)‘s stock had its “buy” rating restated by D. Boral Capital in a research note issued on Monday,Benzinga reports. They presently have a $4.80 price target on the stock, down from their previous price target of $9.00. D. Boral Capital’s price objective would indicate a potential upside of 20.00% […]
Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report)‘s stock had its “buy” rating restated by D. Boral Capital in a research note issued on Monday,Benzinga reports. They presently have a $4.80 price target on the stock, down from their previous price target of $9.00. D. Boral Capital’s price objective would indicate a potential upside of 20.00% […]
